Tech Company Financing Transactions

Athenix Funding Round

Intersouth Partners, Polaris Partners and Boston Millennia Partners participated in a $12.5 million Series B funding round for Athenix. The round was recorded on 1/20/2004.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

108 T.W. Alexander Dr.
Research Triangle Park, NC 27709
USA

Phone

(919) 328-4100

Website

www.athenixcorp.com

Email Address

[email protected]

Overview

Athenix is a leading biotechnology company developing innovative, high-value, bio-industrial products for the Agricultural and Chemical businesses using genetic traits from microbes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mike Koziel

        

Chief Financial Officer

Mark Hahn

        

Chief Operating Officer

Markus Andres

        

VP - Bus. Development

Scott Uknes

        

VP - Product Management

Nadine Carozzi

        

VP - R & D

Nicholas Duck

        

Browse more venture capital transactions:

Prev: 1/20/2004: ZettaCore venture capital transaction
Next: 1/20/2004: Phytomedics venture capital transaction

Share this article

Where The Data Comes From

We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary